J. Weber, D. Angelo, S. Minor, and D. , Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial, The Lancet Oncology, vol.16, issue.4, pp.375-384, 2015.
DOI : 10.1016/S1470-2045(15)70076-8

L. Vaillant, P. Bernard, and P. Joly, Evaluation of Clinical Criteria for Diagnosis of Bullous Pemphigoid, Archives of Dermatology, vol.134, issue.9, pp.1075-1080, 1998.
DOI : 10.1001/archderm.134.9.1075
URL : http://archderm.jamanetwork.com/data/journals/derm/4618/dst8011.pdf

J. Schindler, K. Querfeld, and C. , Autoimmune bullous skin disorders with immune checkpoint inhibitors targeting PDÀ1 and PD-L1, Cancer Immunol Res, vol.4, pp.383-389, 2016.